DK1912647T3 - Quinolinderivater som antibakterielle midler - Google Patents

Quinolinderivater som antibakterielle midler

Info

Publication number: DK1912647T3
Authority: DK; Denmark
Prior art keywords: antibacterial agents; quinoline derivatives; quinoline; derivatives; antibacterial
Prior art date: 2005-08-03

Application number

DK06778081.7T

Other languages

English (en)

Inventor

Jera Me Emile Georges Guillemont

David Francis Alain Lancois

Koenraad Jozef Lodewijk Marcel Andries

Anil Koul

Elisabeth Therese Jeanne Pasquier

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-08-03

Filing date

2006-07-31

Publication date

2013-12-02

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35768940&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1912647(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-07-31 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2013-12-02 Application granted granted Critical

2013-12-02 Publication of DK1912647T3 publication Critical patent/DK1912647T3/da

Links

SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical class N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 title 1
239000003242 anti bacterial agent Substances 0.000 title 1
229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Quinoline Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

DK06778081.7T 2005-08-03 2006-07-31 Quinolinderivater som antibakterielle midler DK1912647T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP05107159		2005-08-03
PCT/EP2006/064856 WO2007014940A2 (en)	2005-08-03	2006-07-31	Quinoline derivatives as antibacterical agents

Publications (1)

Publication Number	Publication Date
DK1912647T3 true DK1912647T3 (da)	2013-12-02

Family

ID=35768940

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK06778081.7T DK1912647T3 (da)	2005-08-03	2006-07-31	Quinolinderivater som antibakterielle midler

Country Status (28)

Country	Link
US (1)	US8017606B2 (da)
EP (1)	EP1912647B1 (da)
JP (1)	JP5410753B2 (da)
KR (1)	KR101337237B1 (da)
CN (1)	CN101277695B (da)
AR (1)	AR054889A1 (da)
AU (1)	AU2006274879B2 (da)
BR (1)	BRPI0614524B8 (da)
CA (1)	CA2615901C (da)
CY (1)	CY1114908T1 (da)
DK (1)	DK1912647T3 (da)
EA (1)	EA014832B1 (da)
ES (1)	ES2437575T3 (da)
HR (1)	HRP20131116T1 (da)
IL (1)	IL189141A (da)
JO (1)	JO2952B1 (da)
MX (1)	MX2008001602A (da)
MY (1)	MY148241A (da)
NO (1)	NO341247B1 (da)
NZ (1)	NZ565283A (da)
PL (1)	PL1912647T3 (da)
PT (1)	PT1912647E (da)
RS (1)	RS53065B (da)
SI (1)	SI1912647T1 (da)
TW (1)	TWI381839B (da)
UA (1)	UA95916C2 (da)
WO (1)	WO2007014940A2 (da)
ZA (1)	ZA200801108B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2512364B2 (ja)	1992-03-02	1996-07-03	共栄電工株式会社	筒状の被加工物の内面研磨方法および装置
ATE444068T1 (de) *	2004-01-23	2009-10-15	Janssen Pharmaceutica Nv	Chinolinderivate und ihre verwendung als mycobakterielle inhibitoren
JO2952B1 (en)	2005-08-03	2016-03-15	جانسين فارماسوتيكا ان. في	Quinoline derivatives acting as antibacterial agents
JO2683B1 (en) *	2006-12-06	2013-03-03	جانسين فارماسوتيكا ان. في	Quinoline antibacterial derivatives
JO3271B1 (ar) *	2006-12-06	2018-09-16	Janssen Pharmaceutica Nv	مشتقات الكوينولين المضادة للجراثيم
CA2711912A1 (en) *	2008-01-14	2009-07-23	Jyoti Chattopadhyaya	Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivates as anti-mycobacterial agents
JP5246715B2 (ja) *	2009-01-27	2013-07-24	独立行政法人科学技術振興機構	蛋白質架橋阻害剤およびその用途
WO2010144102A1 (en) *	2009-06-09	2010-12-16	The United States Of America, As Represented By The Secretary Of The Army, On Behalf Of U.S. Army Medical Research And Material Command	Pentafluorosulfanyl analogs of mefloquine
US9133167B2 (en)	2012-04-27	2015-09-15	Janssen Pharmaceutica Nv	Antibacterial quinoline derivatives
KR102110366B1 (ko)	2012-04-27	2020-05-14	얀센 파마슈티카 엔.브이.	항균성 퀴놀린 유도체
CN104884448A (zh)	2012-10-16	2015-09-02	詹森药业有限公司	Rorγt的杂芳基连接的喹啉基调节剂
JP6466335B2 (ja)	2012-10-16	2019-02-06	ヤンセンファーマシューティカエヌ．ベー．	ＲＯＲ−γ−Ｔのメチレン連結キノリニルモジュレーター
US9309222B2 (en)	2012-10-16	2016-04-12	Janssen Pharmaceutica Nv	Phenyl linked quinolinyl modulators of RORγt
US9642858B2 (en)	2012-10-30	2017-05-09	University of Pittsburgh—of the Commonwealth System of Higher Education	Use of resazurin, or analogs thereof, for antibacterial therapy
US9284308B2 (en)	2013-10-15	2016-03-15	Janssen Pharmaceutica Nv	Methylene linked quinolinyl modulators of RORγt
KR20160068948A (ko)	2013-10-15	2016-06-15	얀센 파마슈티카 엔.브이.	RORyt의 이차 알코올 퀴놀리닐 조절제
US9221804B2 (en)	2013-10-15	2015-12-29	Janssen Pharmaceutica Nv	Secondary alcohol quinolinyl modulators of RORγt
US10555941B2 (en)	2013-10-15	2020-02-11	Janssen Pharmaceutica Nv	Alkyl linked quinolinyl modulators of RORγt
US9328095B2 (en)	2013-10-15	2016-05-03	Janssen Pharmaceutica Nv	Heteroaryl linked quinolinyl modulators of RORgammat
CN105873439A (zh)	2013-10-15	2016-08-17	詹森药业有限公司	RORγt的烷基连接的喹啉基调节剂
KR20160068956A (ko)	2013-10-15	2016-06-15	얀센 파마슈티카 엔.브이.	RORyT의 퀴놀리닐 조절제
US9403816B2 (en)	2013-10-15	2016-08-02	Janssen Pharmaceutica Nv	Phenyl linked quinolinyl modulators of RORγt
GB201904796D0 (en) *	2019-04-04	2019-05-22	Univ Sheffield	Antimicrobial agent
AR121683A1 (es) *	2020-03-31	2022-06-29	Takeda Pharmaceuticals Co	Derivados de n-heteroarilalquil-2-(heterociclil y heterociclilmetil)acetamida como agonistas de sstr4
AR121682A1 (es)	2020-03-31	2022-06-29	Takeda Pharmaceuticals Co	Derivados de n-(heterociclil y heterociclilalquil)-3-bencilpiridin-2-amina como agonistas de sstr4

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9317491D0 (en) *	1993-08-23	1993-10-06	Fujisawa Pharmaceutical Co	New compound and a process for preparation thereof
US6103905A (en) *	1997-06-19	2000-08-15	Sepracor, Inc.	Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6376670B1 (en) *	1997-06-19	2002-04-23	Sepracor Inc.	Quinoline-indole antimicrobial agents, uses and compositions related thereto
GB9914486D0 (en) *	1999-06-21	1999-08-18	Smithkline Beecham Plc	Medicaments
GB9917408D0 (en) *	1999-07-23	1999-09-22	Smithkline Beecham Plc	Compounds
GB0101577D0 (en) *	2001-01-22	2001-03-07	Smithkline Beecham Plc	Compounds
TW200409637A (en) *	2002-06-26	2004-06-16	Glaxo Group Ltd	Compounds
PT1527050E (pt) *	2002-07-25	2010-06-22	Janssen Pharmaceutica Nv	Derivados de quinolina e sua utilização como inibidores de micobactérias
EP1551829B1 (de) *	2002-10-10	2010-04-07	Morphochem Aktiengesellschaft Für Kombinatorische Chemie	Neue verbindungen mit antibakterieller aktivität
DE10316081A1 (de)	2003-04-08	2004-10-21	Morphochem AG Aktiengesellschaft für kombinatorische Chemie	Neue Verbindungen mit antibakterieller Aktivität
EA011211B1 (ru) *	2003-11-20	2009-02-27	Янссен Фармацевтика Н. В.	7-фенилалкилзамещённые 2-хинолиноны и 2-хиноксалиноны в качестве ингибиторов поли(адф-рибоза)полимеразы
EP1709012B1 (en) *	2003-12-05	2015-07-29	Janssen Pharmaceutica NV	6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose)polymerase inhibitors
ATE444068T1 (de) *	2004-01-23	2009-10-15	Janssen Pharmaceutica Nv	Chinolinderivate und ihre verwendung als mycobakterielle inhibitoren
JO2952B1 (en)	2005-08-03	2016-03-15	جانسين فارماسوتيكا ان. في	Quinoline derivatives acting as antibacterial agents

2006
- 2006-07-18 JO JO2006233A patent/JO2952B1/en active
- 2006-07-31 PT PT67780817T patent/PT1912647E/pt unknown
- 2006-07-31 ES ES06778081.7T patent/ES2437575T3/es active Active
- 2006-07-31 CA CA2615901A patent/CA2615901C/en active Active
- 2006-07-31 NZ NZ565283A patent/NZ565283A/en not_active IP Right Cessation
- 2006-07-31 JP JP2008524508A patent/JP5410753B2/ja not_active Expired - Fee Related
- 2006-07-31 WO PCT/EP2006/064856 patent/WO2007014940A2/en not_active Ceased
- 2006-07-31 AU AU2006274879A patent/AU2006274879B2/en not_active Ceased
- 2006-07-31 EP EP06778081.7A patent/EP1912647B1/en active Active
- 2006-07-31 SI SI200631705T patent/SI1912647T1/sl unknown
- 2006-07-31 US US11/997,182 patent/US8017606B2/en active Active
- 2006-07-31 KR KR1020087005066A patent/KR101337237B1/ko not_active Expired - Fee Related
- 2006-07-31 HR HRP20131116TT patent/HRP20131116T1/hr unknown
- 2006-07-31 RS RS20130539A patent/RS53065B/sr unknown
- 2006-07-31 DK DK06778081.7T patent/DK1912647T3/da active
- 2006-07-31 BR BRPI0614524A patent/BRPI0614524B8/pt not_active IP Right Cessation
- 2006-07-31 PL PL06778081T patent/PL1912647T3/pl unknown
- 2006-07-31 MX MX2008001602A patent/MX2008001602A/es active IP Right Grant
- 2006-07-31 CN CN200680036637XA patent/CN101277695B/zh not_active Expired - Fee Related
- 2006-07-31 EA EA200800501A patent/EA014832B1/ru unknown
- 2006-07-31 UA UAA200801433A patent/UA95916C2/ru unknown
- 2006-08-01 MY MYPI20063726A patent/MY148241A/en unknown
- 2006-08-02 AR ARP060103371A patent/AR054889A1/es not_active Application Discontinuation
- 2006-08-02 TW TW095128223A patent/TWI381839B/zh not_active IP Right Cessation
2008
- 2008-01-31 IL IL189141A patent/IL189141A/en active IP Right Grant
- 2008-02-01 ZA ZA200801108A patent/ZA200801108B/xx unknown
- 2008-02-25 NO NO20080955A patent/NO341247B1/no not_active IP Right Cessation
2013
- 2013-12-11 CY CY20131101116T patent/CY1114908T1/el unknown

Also Published As

Publication number	Publication date
MX2008001602A (es)	2008-02-19
EA014832B1 (ru)	2011-02-28
MY148241A (en)	2013-03-29
NO20080955L (no)	2008-02-25
NZ565283A (en)	2011-07-29
CA2615901A1 (en)	2007-02-08
JP2009503024A (ja)	2009-01-29
US20080255116A1 (en)	2008-10-16
HK1124233A1 (en)	2009-07-10
BRPI0614524B1 (pt)	2020-05-19
PL1912647T3 (pl)	2014-02-28
IL189141A0 (en)	2008-08-07
ES2437575T3 (es)	2014-01-13
BRPI0614524B8 (pt)	2021-05-25
AR054889A1 (es)	2007-07-25
AU2006274879B2 (en)	2013-01-10
JP5410753B2 (ja)	2014-02-05
CA2615901C (en)	2014-06-03
AU2006274879A1 (en)	2007-02-08
CN101277695B (zh)	2011-12-14
TW200744594A (en)	2007-12-16
RS53065B (sr)	2014-04-30
KR101337237B1 (ko)	2013-12-06
EP1912647B1 (en)	2013-09-11
EA200800501A1 (ru)	2008-10-30
CN101277695A (zh)	2008-10-01
ZA200801108B (en)	2009-05-27
UA95916C2 (ru)	2011-09-26
KR20080038380A (ko)	2008-05-06
JO2952B1 (en)	2016-03-15
WO2007014940A8 (en)	2007-07-05
IL189141A (en)	2015-10-29
CY1114908T1 (el)	2016-12-14
BRPI0614524A2 (pt)	2011-04-05
US8017606B2 (en)	2011-09-13
EP1912647A2 (en)	2008-04-23
NO341247B1 (no)	2017-09-25
PT1912647E (pt)	2013-12-05
HRP20131116T1 (hr)	2013-12-20
TWI381839B (zh)	2013-01-11
WO2007014940A2 (en)	2007-02-08
WO2007014940A3 (en)	2007-03-29
SI1912647T1 (sl)	2014-01-31

Publication	Publication Date	Title
IL189141A0 (en)	2008-08-07	Quinoline derivatives as antibacterial agents
IL187904A0 (en)	2008-03-20	Quinoline derivatives as antibacterial agents
IL189142A0 (en)	2008-08-07	Quinoline derivatives as antibacterial agents
ATE467619T1 (de)	2010-05-15	Antibakterielle chinolinderivate
IL188395A0 (en)	2008-08-07	Quinoline derivatives as antibacterial agents
ZA200801106B (en)	2009-09-30	Quinoline derivatives as antibacterial agents
ATE509915T1 (de)	2011-06-15	Antibakterielle chinolinderivate
IL188393A0 (en)	2008-08-07	Quinoline derivatives as antibacterial agents
IL188394A0 (en)	2008-08-07	Quinoline derivatives as antibacterial agents
DK2086941T3 (da)	2010-08-09	Antibakterielle quinolinderivater
ATE486061T1 (de)	2010-11-15	Antibakterielle chinolinderivate
ZA200710698B (en)	2009-03-25	Quinoline derivatives as antibacterial agents